Skip to main content
Contact Us
Subscribe
E-Edition
93°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
4D Molecular Therapeutics Inc
(NQ:
FDMT
)
14.96
+0.49 (+3.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 4D Molecular Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
4D Molecular Therapeutics Outlines Pivotal Development Plans For Cystic Fibrosis, Rare Inherited Disease
March 28, 2024
4D Molecular Therapeutics' latest advancements in CF treatment. Get insights into their 4D-710 aerosolized genetic medicine for cystic fibrosis lung disease, including Phase 1/2 AEROW trial updates and...
Via
Benzinga
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis
March 28, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT to Participate in Upcoming Investor Conferences
March 04, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4D Molecular Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
March 01, 2024
Via
Benzinga
What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics
February 07, 2024
Via
Benzinga
Why Is 4D Molecular (FDMT) Stock Up 85% Today?
February 05, 2024
Investors in 4D Molecular Therapeutics and FDMT stock are seeing big gains today, as the stock surges 80% on positive trial results.
Via
InvestorPlace
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
February 29, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Presents Interim Data from 4D-310 INGLAXA Phase 1/2 Clinical Trials for Fabry Disease Cardiomyopathy at WORLDSymposium™ 2024
February 12, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?
February 08, 2024
Adverum Biotechnologies' Ixo-vec gene therapy for wet AMD. Preliminary LUNA Phase 2 trial data show safety, efficacy, and significant treatment burden reduction.
Via
Benzinga
Why 4D Molecular Therapeutics (FDMT) Stock Is Diving
February 07, 2024
4D Molecular Therapeutics shares are trading lower by 12.7% Wednesday afternoon. The company announced pricing of an upsized underwritten public offering.
Via
Benzinga
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
February 06, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4D Molecular Therapeutics' 4D-150 Phase 2 Data Met Investor Expectations, Analyst Boosts Forecast
February 06, 2024
4D Molecular Therapeutics' 4D-150 Phase 2 results for wet AMD treatment. BMO Capital optimistic, target price raised to $70.
Via
Benzinga
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
February 05, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
Crude Oil Moves Higher; Caterpillar Posts Upbeat Earnings
February 05, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 200 points on Monday. The Dow traded down 0.53% to 38,450.28 while the NASDAQ fell 0.11% to 15,612.52. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 05, 2024
Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 05, 2024
Via
Benzinga
Gold Moves Lower; ISM Services PMI Beats Estimates
February 05, 2024
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday. The Dow traded down 1.04% to 38,253.72 while the NASDAQ fell 0.86% to 15,493.97. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
4D Molecular Therapeutics Inc. (NASDAQ: FDMT) Leading the Way in Monday Trading Based on Percentage Gain
February 05, 2024
Via
Investor Brand Network
Why Is Eye Disease-Focused 4D Molecular Therapeutics Stock Shooting Higher Today?
February 05, 2024
4D Molecular Therapeutics data in wet AMD treatment. Phase 2 PRISM trial shows promising results - 89% reduction in anti-VEGF injections, stable visual acuity.
Via
Benzinga
Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday
February 05, 2024
U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Tumbles 150 Points; McDonald's Sales Miss Views
February 05, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling around 150 points on Monday. Following the market opening Monday, the Dow traded down 0.41% to 38,494.03 while the NASDAQ fell...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 05, 2024
Via
Benzinga
Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
February 05, 2024
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 05, 2024
The biggest pre-market stock movers are starting off the trading week as we check out all of the hottest news for Monday morning!
Via
InvestorPlace
4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD
February 03, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT to Host Corporate Webcast to Discuss Interim Data from Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 in Wet AMD Patients with Severe Disease Activity & High Treatment Burden
January 29, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Receives Rare Pediatric Disease Designation from FDA for Aerosolized 4D-710 for Treatment of Cystic Fibrosis Lung Disease
January 23, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Highlights Recent Clinical Pipeline Progress, Near-Term Milestones and Organizational Updates
January 04, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases
January 03, 2024
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.